TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Modified Mini Mental State Examination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Region-level positive predictive value (PPV) of [18F]PSMA-1007
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-level correct detection rate of [18F]PSMA-1007
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loco-regional control after 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Hoehn and Yahr Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Movement Disorder Society Unified Parkinson's Disease rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptive behavior function
Endpoint domain: Life impact
Endpoint subdomain: Functional outcomes
Primary endpoint: Significantly Delayed Breast Cancer Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of nausea/vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in vascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptance and Action Questionnaire-II (AAQII)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive Fusion Questionnaire-7 (CFQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Southampton Mindfulness Questionnaire (SMQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychotic Symptom Rating Scales (PSYRATS-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primitive (primary) reflexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BREAST-Q validation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQol-5 dimensions validation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital Anxiety and Depression scale (HADS) validation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RAND-36 validation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clavion-Dindo classification validation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of Food Insecurity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bayley-4 language performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amygdala volume on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intranetwork connectivity in Salience and Language networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Parental Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interpersonal Mindfulness in Parenting Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peace of mind
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of newly diagnosed atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective response rates (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: fMRI brain activation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of treatment emergent serious adverse events (TE-SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: GMT of neutralizing antibody to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMFR and percentage of participants with ≥4-fold rise of neutralizing antibody to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of SARS-CoV-2 RBD-binding IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMFR and percentage of participants with ≥4-fold rise of SARS-CoV-2 RBD-binding IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cell-mediated response for both Th1 and Th2 cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: early change in genito-urinary (GU) toxicities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early change in reported EPIC-26 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: late change in genito-urinary (GU) toxicities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: late change in reported EPIC-26 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: early change in sexual health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: late change in sexual health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Difference in eosinophil percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in gene expression of IL-13 activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incremental cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Erectile Dysfunction improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Peripheral perfusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with newly diagnosed pancreatic ductal adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Evaluation of Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-operative follow-up: patient reported hearing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-operative follow-up: measured hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visual analog scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quick The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Fugl-Meyer Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Mean score on the Asthma Control Questionnaire (ACQ-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number of asthma-related urgent care visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: BCG load ascertainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma glucose change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Inflammatory Biomarkers Measured by ELISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Regional Lung Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Fast-Twitch Skeletal Muscle Troponin I Measured by ELISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Physical examination abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in clinical laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in 12-lead ECG
Endpoint domain: Adverse events/effects
Primary endpoint: Mean difference in peak change in serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hamilton Depression Rating Scale-24 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sex ratio at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: change in the best corrected visual acuity in meters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the retina and macula measurements by Optical coherence tomography (OCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapy-related symptom checklist for children (TRSC-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in stool consistency based on the Bristol Stool Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in faecal microbiota using 16s Metagenome sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abbreviated physical examinations in terms of frequency of sensation of defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of participants with IGA of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Prenatal Screening Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fecal occult blood concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dapagliflozin half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dapagliflozin Volume of distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dapagliflozin AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of AST and ALT and normal IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Deep biochemical remission of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lack of biochemical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back-Saver Sit-and-Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Diagnosis of COVID-19 or other respiratory viral infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of respiratory morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Non-invasive oscillometry (NiOS) measurements of pulmonary mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinically successful PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 1,25 dihydroxivitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FGF-23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Klotho
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline mental health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Overactive Bladder Symptoms Score (OABSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Maximum Urinary Flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Post-Void Residual (PVR) Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: serious infectious complication
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of diagnosis of IBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of prognosis of IBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprocedural bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Grade of anterior chamber cells (ACC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: decrease in the wall motion score index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of the Iron AI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Streptomutans count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary PH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caries risk level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative sensory testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of body awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of treatment in localized psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in LDL cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with maintenance of the major Cobb angle ≤ 40 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Organ reservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success in hair preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device related or procedure related severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of pharyngocutaneous fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage change in Ki67
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of maximum EMG amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Rating Scale of Global impression of change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Implicit wanting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: survival at hospital discharge without severe morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Change in pain score 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain score 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Product Appeal Scoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Harm Perceptions (Absolute) Scoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to Try Product Scoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weakness in neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Symptoms and signs of muscle weakness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Motor developmental delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: changes in Visual analogue scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of device deficiencies
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and frequency of revisions
Endpoint domain: Mortality/survival
Primary endpoint: level of IL35 in tissue biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in total area of GA Lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mishel Uncertainty in Illness Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global Subjective Score 75 (GSS75) rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fMRI Brain Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Double-leg static postural stability sway area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-leg static postural stability sway area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in average SNAP-IV score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of solicited local and systemic post-injection reactions (PIRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic Union Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cancer treatment induced neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Striatal binding of the adenosine A2A receptor ligand [18F]MNI-444
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cardiac Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Oscillatory Power Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Worry about COVID
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes and Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Coronavirus Threat
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of BPD (bronchopulmonary dysplasia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Food intake, kilojoules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Food intake, kilojoules per kilogram body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical success by site of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Pain Inventory pain severity subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Pain Inventory pain interference subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improved morphokinetics parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in physical work capacity (PWC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative SIRS or sepsis prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 24 months-progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: percentage of TLR4+ cells in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percentage of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who achieve the maximum dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum AMH (sAMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Brain Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Stress levels in palliative caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Global Health - Mental Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Global Health - Physical Health Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients who enroll in a clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients who remain in a clinical trial to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with moderate-severe exacerbations of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hormone Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quantified bioprosthetic micro-calcification activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subclinical Leaflet Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Valve dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inpatient hypoglycemia event rates
Endpoint domain: Adverse events/effects
Primary endpoint: change in skin condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient and Observer Scar Assessment Scale Score (POSAS 3.0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post-extubation measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypotension prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in COPD health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of 67Cu-SAR-BBN in terms of Prostate Specific Antigen (PSA) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes